» Articles » PMID: 33348690

Supramolecular and Macromolecular Matrix Nanocarriers for Drug Delivery in Inflammation-Associated Skin Diseases

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2020 Dec 22
PMID 33348690
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Skin is our biggest organ. It interfaces our body with its environment. It is an efficient barrier to control the loss of water, the regulation of temperature, and infections by skin-resident and environmental pathogens. The barrier function of the skin is played by the stratum corneum (SC). It is a lipid barrier associating corneocytes (the terminally differentiated keratinocytes) and multilamellar lipid bilayers. This intricate association constitutes a very cohesive system, fully adapted to its role. One consequence of this efficient organization is the virtual impossibility for active pharmaceutical ingredients (API) to cross the SC to reach the inner layers of the skin after topical deposition. There are several ways to help a drug to cross the SC. Physical methods and chemical enhancers of permeation are a possibility. These are invasive and irritating methods. Vectorization of the drugs through nanocarriers is another way to circumvent the SC. This mini-review focuses on supramolecular and macromolecular matrices designed and implemented for skin permeation, excluding vesicular nanocarriers. Examples highlight the entrapment of anti-inflammatory API to treat inflammatory disorders of the skin.

Citing Articles

The Association of Oleic Acid and Dexamethasone Acetate into Nanocapsules Enables a Reduction in the Effective Corticosteroid Dose in a UVB Radiation-Induced Sunburn Model in Mice.

Pegoraro N, Gehrcke M, Camponogara C, Pessano Fialho M, Cruz L, Oliveira S Pharmaceutics. 2024; 16(2).

PMID: 38399236 PMC: 10892665. DOI: 10.3390/pharmaceutics16020176.

References
1.
Madan J, Khude P, Dua K . Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery. Int J Pharm Investig. 2014; 4(2):60-4. PMC: 4083535. DOI: 10.4103/2230-973X.133047. View

2.
Praca F, Viegas J, Peh H, Garbin T, Medina W, Bentley M . Microemulsion co-delivering vitamin A and vitamin E as a new platform for topical treatment of acute skin inflammation. Mater Sci Eng C Mater Biol Appl. 2020; 110:110639. DOI: 10.1016/j.msec.2020.110639. View

3.
Fruchon S, Poupot R . Pro-Inflammatory Versus Anti-Inflammatory Effects of Dendrimers: The Two Faces of Immuno-Modulatory Nanoparticles. Nanomaterials (Basel). 2017; 7(9). PMC: 5618362. DOI: 10.3390/nano7090251. View

4.
Viegas J, Praca F, Caron A, Suzuki I, Silvestrini A, Medina W . Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug Deliv Transl Res. 2020; 10(3):646-660. DOI: 10.1007/s13346-020-00723-6. View

5.
Proksch E, Brandner J, Jensen J . The skin: an indispensable barrier. Exp Dermatol. 2008; 17(12):1063-72. DOI: 10.1111/j.1600-0625.2008.00786.x. View